We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

The Future of Targeted Therapy in Rheumatology: Biologics or Small Molecules?

News   Aug 12, 2014

 
The Future of Targeted Therapy in Rheumatology: Biologics or Small Molecules?
 
 
 

RELATED ARTICLES

University of California Boycotts Publishing Giant Elsevier

News

In a bold move to push for open access to publicy-funded research, the University of California has terminated its multimillion-dollar subscriptions with Elsevier.

READ MORE

Tobacco Plants Transformed Into Green Bioreactors to Produce Human Proteins

News

This work is the first of its kind to demonstrate that this functional human protein can be produced in plant cells.

READ MORE

GE Inks $21 Billion Biopharma Sale to Danaher, a U-turn Decision

News

This week, Danaher announced a definitive agreement to purchase General Electric's Biopharma business for a cash purchase price of $21.4 billion. Factoring tax benefits from the structure of the deal, the net purchase price is about $20 billion.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE